Animal studies in spinal cord injury: a systematic review of methylprednisolone.
The objective of this study was to examine whether animal studies can reliably be used to determine the usefulness of methylprednisolone (MP) and other treatments for acute spinal cord injury (SCI) in humans. This was achieved by performing a systematic review of animal studies on the effects of MP administration on the functional outcome of acute SCI. Data were extracted from the published articles relating to: outcome; MP dosing regimen; species/strain; number of animals; methodological quality; type of injury induction; use of anaesthesia; functional scale used; and duration of follow-up. Subgroup analyses were performed, based on species or strain, injury method, MP dosing regimen, functional outcome measured, and methodological quality. Sixty-two studies were included, which involved a wide variety of animal species and strains. Overall, beneficial effects of MP administration were obtained in 34% of the studies, no effects in 58%, and mixed results in 8%. The results were inconsistent both among and within species, even when attempts were made to detect any patterns in the results through subgroup analyses. The results of this study demonstrate the barriers to the accurate prediction from animal studies of the effectiveness of MP in the treatment of acute SCI in humans. This underscores the need for the development and implementation of validated testing methods.
Akhtar
Aysha Z
AZ
Physicians Committee for Responsible Medicine, Washington, DC, USA. aysha.akhtar@oxfordanimalethics.com
Pippin
John J
JJ
Sandusky
Chad B
CB
D000818:Animals; D002415:Cats; D004195:Disease Models, Animal; D004285:Dogs; D000882:Haplorhini; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use*; D051379:Mice; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D011237:Predictive Value of Tests; D011817:Rabbits; D051381:Rats; D020127:Recovery of Function; D012756:Sheep; D013045:Species Specificity; D013119:Spinal Cord Injuries / Q000188:drug therapy* / Q000503:physiopathology
D018696:Neuroprotective Agents; D008775:Methylprednisolone